Nanogen announces $20 million financing

September 4, 2007 — Nanogen Inc., developer of advanced diagnostic products, has entered into a definitive agreement for a $20 million registered offering to institutional investors of Senior Convertible Notes and warrants. Seven Hills Partners LLC served as the placement agent for the transaction.

Howard C. Birndorf, Nanogen chairman and CEO, said, “This financing provides the company with a vehicle for long term continued investment in the company and allows us to focus on our core objectives of managing the business and improving our EBITDA performance.”


Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.